SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: Starlight who wrote (773)5/4/2000 4:20:00 PM
From: Chip McVickar  Read Replies (1) | Respond to of 1154
 
Yes, but those kind of statements are often sold hard at resistence levels. It will take some fundamental news to bring them back. Like a new drug or treatment derived form the Genomic work.

It'll come...someday..?

Chip



To: Starlight who wrote (773)5/4/2000 4:36:00 PM
From: OldAIMGuy  Respond to of 1154
 
Hi Betty, In this week's Value Line Index Section (Page 33, bottom) there were ten biotech/medical related stocks listed in their "Worst Performers - Last 13 Weeks" screen. That's ten out of forty-one!

Any time I see that many companies from one sector there's been a major sector shift. It may not be the end of the Bio-Bashing, but it sure shows we're nearing the end. The 13 week losses ranged from -50% to -76%. Yikes!

Best regards, Tom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News